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Abstract
Consensus is gathering that antimicrobial peptides that exert their antibacterial action at the membrane level must reach a
local concentration threshold to become active. Studies of peptide interaction with model membranes do identify such
disruptive thresholds but demonstrations of the possible correlation of these with the in vivo onset of activity have only
recently been proposed. In addition, such thresholds observed in model membranes occur at local peptide concentrations
close to full membrane coverage. In this work we fully develop an interaction model of antimicrobial peptides with
biological membranes; by exploring the consequences of the underlying partition formalism we arrive at a relationship that
provides antibacterial activity prediction from two biophysical parameters: the affinity of the peptide to the membrane and
the critical bound peptide to lipid ratio. A straightforward and robust method to implement this relationship, with potential
application to high-throughput screening approaches, is presented and tested. In addition, disruptive thresholds in model
membranes and the onset of antibacterial peptide activity are shown to occur over the same range of locally bound peptide
concentrations (10 to 100 mM), which conciliates the two types of observations.
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Introduction
Antimicrobial peptides (AMPs) constitute a broadly defined
class of short, cationic peptides produced by virtually all
organisms. Since their discovery microbiological methodologies
have been employed to characterize their antibacterial action
[1,2]. In turn, the relative simplicity in sequence and secondary
structure of AMPs, together with mechanisms that depend largely
on membrane interaction [3], made biophysical methodologies the
tools of choice to describe the molecular level action of AMPs. A
gap, however, separates the two distinct approaches: information
from biological studies is seldom correlated to the findings on
peptide behavior at the molecular level.
Threshold behavior is a point where the two fields come
together. On one hand, the activity of an AMP is commonly
expressed as the threshold concentration upon which bacterial
growth is inhibited (the MIC, or minimum inhibitory concentra-
tion). On the other, biophysical studies with model phospholipid
membranes often identify concentration thresholds upon which
the peptide behavior becomes disruptive [4–10]–tipically through
pore formation or membrane lysis. This is an expected point of
convergence between biological activity and molecular-level
behavior given that the bacterial membrane has long been
identified as the primary target for most AMPs; indeed,
connections between in vivo MICs and thresholds in model
membranes have been recently proposed [9,11]. In this work we
describe a simple physical-chemical framework that models this
correlation. We then fully explore its predictive power, with good
predictions for the activities of the AMPs Omiganan and BP100.
Analysis
Model background
Our analysis is centered on the comparison of local membrane
concentrations at the threshold events of the MIC and of
molecular-level membrane disruption. It therefore requires that
those concentrations be known or somehow estimated.
In studies with model membranes bound concentrations can
usually be directly extracted from published data when expressed
as the peptide-to-lipid ratio (P : L) at which the threshold occurs
(see the Supporting Information for involved approximations in
this approach). Threshold AMP P : L values commonly fall in the
1:10 to 1:100 range [5,9], corresponding to a 13 to 130 mM range
of membrane-bound peptide concentrations.
Calculating the in vivo amount of peptide molecules bound to
the bacterial membrane at the MIC is, however, not as
straightforward. To obtain an estimate for this value we assumed
that the distribution of the peptide between the medium and the
bacterial membrane obeys a simple Nernst equilibrium [12].
Under this approach, commonly used to describe binding to
model membranes [3,13,14] and in which these are considered an
immiscible lipidic phase, the partition constant Kp is defined as a
concentration ratio:
Kp~
½PL
½PW
ð1Þ
where ½PL and ½PW are the peptide concentration in the lipidic
and aqueous phases, respectively–the Supporting Information
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(Text S1) details some simplifications implicit in this definition, as
well as the conversion from other types of binding constants [14].
From Equation 1, the fraction of peptide molecules in the lipidic
phase (XL) can be obtained as
XL~
KpcL½L
1zKpcL½L
ð2Þ
where ½L is the total lipid concentration and cL the molar volume
of the lipid phase. Finally, the local peptide concentration in a
membrane at a lipid concentration ½L is given by
½PL~
XL½Ptotal
cL½L
ð3Þ
where ½Ptotal is the peptide concentration over the global volume.
Calculation of the bound peptide concentration requires that a
Kp for the interaction with bacterial membranes is known. We
assumed that an AMP interacts with such membranes and their
model counterparts with similar affinity and, so, that binding or
partition constants determined for the latter are acceptable
approximations; a typical [9] AMP-membrane Kp of 5|10
4 was
used. Equations 2 and 3 also require knowledge of the amount of
membrane lipid available for peptide binding under MIC assay
conditions (thus termed ½LMICassay). This value was estimated
assuming a bacterium dry mass of 489 fg [15], 8.2% of which are
phospholipids [16] (data for E. coli); admitting a maximum
bacterial titre of 106 cfu=mL [17] this yields an ½LMICassay of
40 ng=mL, or 58 nM if all the phospholipids are approximated to
have the molecular weight of dipalmitoylphosphatidylethanola-
mine (691:96 gmol{1). This value is in good agreement with, and
corroborates, published results from distinct calculations based on
bacterial surface area [18,19] (25 and 66 nM, respectively).
Lastly, a ½P total of 2 mM was assumed–a typical MIC value
for an AMP–together with a cL value of 0:76M
{1, corresponding
to the density of a fluid bilayer [20].
With the above parameters only 0:22% of the total peptide is
predicted, by Equation 2, to bind bacterial membranes in a MIC
assay. This very low fraction indicates that almost all peptide
remains in the aqueous phase but it does not mean that the local
concentration in the membrane is low: indeed, Equation 3,
indicates a bound concentration of 100mM. This value–about 13
phospholipids per bound peptide–falls in the range of the bound
threshold concentrations in model membranes mentioned earlier,
supporting the parallel between those and the MIC. The high
obtained concentration also supports the proposed [9] view that,
rather than being unphysiological, such high bound AMP
concentrations are expectable events in vivo (indeed, even higher
local concentrations in bacteria have been measured [21],
although the lack of physiological ionic strength in that experiment
is likely to have exacerbated the degree of binding).
Activity prediction
The usefulness of our model was extended, in a more
quantitative sense, to predict antimicrobial activities from known
threshold occurrences in model membranes: Equations 2 and 3
were combined to define P : L as a function of ½Ptotal, Kp and ½L:
P : L~
1
½PtotalKpcL
z
½L
½Ptotal
 {1
: ð4Þ
Under the conditions where activity is triggered in vivo ½P total is
the MIC, P : L is the disruption threshold in the membrane (here
termed P : L) and ½L is of the magnitude of ½LMICassay:
P : L~(
1
MIC:KpcL
z
½LMICassay
MIC
){1&MIC:KpcL: ð5Þ
The approximation in the expression is possible because the
nanomolar values of ½LMICassay are two to three orders of
magnitude smaller than the typical micromolar MICs [1],
and, given average values for AMP partition constants [9],
½LMICassay=MIC becomes negligible for the result. Finally, we
arrive at the relationship between the MIC of an AMP and its
disruptive behavior (P : L) on a model membrane:
MIC~
P : L
KpcL
: ð6Þ
At this point it should be noted that the disruption threshold
P : L need not refer exclusively to membrane lysis or poration. If
a peptide requires a given membrane concentration to translocate
into the cell–even if it does so without leaking it, and subsequently
only attacks inner targets–then that will still be a valid P : L to
use in Equation 6.
Equation 6 can be applied on its own to AMP threshold (P : L)
and affinity (Kp) data; however, a linear relationship has been
described between the global peptide and lipid concentrations in a
system when threshold events occur in a membrane [7,22]. An
important feature of this relationship is that its intercept is
equivalent to the MIC estimate defined in Equation 6:
½P~P : L

KpcL
zP : L:½L~MICzP : L:½L ð7Þ
where threshold-point conditions are indicated by an asterisk.
Using Equation 7 MIC values can be estimated from a single
experiment consisting in the determination of peptide vs. lipid
threshold curves with model membranes. No explicit calculation of
Kp or P : L
 values is required–although these can be recovered if
needed [7,22]. Furthermore, because the MIC estimate only
depends on the intercept of the curve, the prediction is robust to
the actual lipid concentrations as long as relative dilutions between
data points are kept. This avoids the need for accurate lipid
quantification and introduces the possibility of using liposomes
that have not been made unilamellar [23,24] (by processes such as
freeze-thaw, extrusion, or sonication), obviating a time- and
resource-consuming step associated to the use of model mem-
branes.
Extension to hemolysis
The model was extended to predict AMP activity against red
blood cells (the minimum hemolytic concentration, or MHC), which
is a common measure for cytotoxicity. The only difference relative to
the MIC prediction approach was the use of ½LMICassay instead of
½LMICassay. An ½LMICassay of 89 mM can be estimated from the
concentration of erythrocytes in the human blood (5|106cells=ml
[25]), their average surface area (150 mm2 [26]), the area per
phospholipid headgroup (0:7 nm2 [27]), and a commonly blood
dilution used in MHC determination of 5% v/v [28,29].
Robustness of the in vivo binding model
In the calculations above an in vivo scenario was severely
simplified in several aspects. It is thus important to assess the
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extent to which approximations affect the obtained practical and
theoretical conclusions.
Estimation of ½LMICassay. The estimation of ½LMICassay from
a bacterium’s weight is prone to error and implicitly assumes an
average value. Likewise, the geometric estimates approximate the
bacterium shape as a sphere or a simple rod, which may not be
entirely accurate; the same stands for the number of leaflets–which
may double if a Gram-negative outer membrane is added–and for
the area per phospholipid–which will surely vary under physiological
conditions. However, the precise value of ½LMICassay is unimportant
because the term containing ½LMICassay in Equation 5 is negligible
when ½LMICassay%MIC, and, since (MIC:Kp:cL){1 is in the order
of 1|101, even an ½LMICassay equal to the MIC will only add
around 10% error to the result. As such, any errors in the
approximation of ½LMICassay will only be of significance if they
impose a correction larger than the two to three orders of magnitude
by which typical MICs are greater than the estimated nanomolar
lipidic concentrations.
Presence of other system components. This model does
not explicitly take into account possible interactions of the peptide
with other system components besides the cell membrane.
However, for such interactions to influence the bound
concentrations–namely by significantly reducing the unbound
amount of peptide–they would have to be extremely strong or the
interacting components would have to be in a very high
concentration. One other cellular constituent present in enough
quantity to potentially sequester a significant amount of peptide is
the anionic Gram-positive peptidoglycan wall. Even so, this
structure has at most only 20 times the volume of the membrane
[30] and, despite not being the subject of many studies, a
proportionally lower affinity towards it was reported for the
peptide omiganan [7], meaning that the presence of peptidoglycan
is roughly equivalent to having a second membrane for the peptide
to interact with. This is well within the allowable error margin
discussed above and it also means that the presence of an outer
membrane in Gram-negative bacteria will not significantly
influence the binding model.
Likewise, bacterial DNA and RNA molecules, being markedly
anionic, could bind a significant portion of the peptide and render
the above conclusions invalid (irrespectively of the physiological
relevance of such interactions [31]). This, however, should have
little impact on the results: there is a total of about 3|107
nucleotide-associated anionic charges per bacterium, taking into
account average amounts of DNA, mRNA and tRNA in an E. coli
cell [32,33]. Under MIC assay conditions that number of anionic
charges would bind 8 nM of a 6+ charged peptide, assuming a
one-to-one charge interaction. This is 0.4% of a 2mM MIC–low
enough not to significantly affect the estimations.
However, while cellular components seem to be unable to
prevent high peptide accumulation in the membrane, the same
might not be true for bulk phase constituents [18,19], which are
often present in milimolar concentrations: one can expect high
ionic strengths to reduce the degree of peptide interaction with the
membrane by neutralizing the effective charge of both the peptide
and the membrane surface, especially if the involved counterions
are not easily displaced. This effect should be compensated for by
using physiological ionic strengths when measuring partition
constants.
Experimental determinaton of P : L
Critical P : L ratios were measured by adding the AMP BP100
(H-KKLFKKILKYL-NH2; synthesized as described elsewhere
[34]) to suspensions of multilamellar vesicles of a 1:2 proportion of
POPC and POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-1-glycerol,
from Avanti Polar Lipids, Inc.) prepared as described elsewhere
[10]. Optical densities of the vesicle suspension were taken for
several lipid-peptide concentration pairs using an MTX Labsys-
tems, Inc. Multiskan EX plate reader and BD Falcon UV-
transparent 96-well plates. Many of the used parameters were
found through the BioNumbers database [35].
Phospholipid mixtures containing 30% POPG, or 25% POPG
and 5% cardiolipin, have been growing in acceptance as accurate
models of the bacterial cell membrane [36]. In this work 67%
POPG were used because threshold events of BP100 were more
clearly observable at higher proportions of anionic lipids. On the
other hand, this proportion might actually better approximate the
charge density of the Gram-negative outer membrane [37]. See
the Supporting Information for an analysis of the possible impact
of using this model system on the conclusions of this work.
Results and Discussion
The predictive model was tested using Equation 6 with the
published parameters and activities of the peptides omiganan
[7,38] and BP100 [10,28,34]. Good agreement between predicted
and observed activities was obtained for both, as summarized in
Table 1.
Equation 7 was then tested with published threshold data for the
same peptides, also with good approximations of the actual MICs
(Figure 1). This simple approach was further tested using threshold
points of BP100 interaction with multilamellar vesicles, deter-
mined from the optical density of the system. This prediction
(Figure 2) is in good agreement with that from Figure 1 and the
observed MICs, the method being indeed robust to the use of
multilamellar vesicles.
Equations 6 and 7 may also be used to estimate other relevant
limits, such as the minimum hemolytic concentration (MHC) of a
peptide. The concentration of erythrocyte membrane phospho-
lipid in an MHC assay (½LMICassay) was estimated to be of almost
Table 1. Estimated and observed activities for the AMPs BP100 and omiganan against Gram-negative bacteria.
Peptide Membrane interaction parameters
a
MIC estimate (mM) Observed MICb (mM)
Kp=10
3 P : L
BP100 [10,34] 30.8–84.1 1 : 8.4 1.9–5.1 2.5–5.0c
Omiganan [7,38] 5.2–43.5 1 : 37.0 0.8–6.8 9.0d
aInteraction parameters for 1:2 POPC:POPG systems, obtained by fluorescence spectroscopy techniques.
bOnly the value/range for the most susceptible strain is indicated.
cRange corresponds to complete growth inhibition of either Pseudomonas syringae or Erwinia amylovora.
dValue corresponds to the MIC90 against Escherichia coli.
doi:10.1371/journal.pone.0028549.t001
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90 mM; this value is of the same order of magnitude as typical
MHC values of hemolytic peptides [29,39], which is a borderline
situation regarding the validity of Equation 5. The method is then
more likely to estimate a lower bound of an MHC than a central
value. Application of Equation 7 to published threshold data on
the interaction of the AMP melittin with different erythrocyte
membrane models [22,40] predicts MHC values from 220.02 to
15:3 mM. Notwithstanding the high ½LMICassay and the wide
prediction interval, the values do overlap with the observed
MHC50 range [29,41], between 0:9 and 2:5mM.
The successful application of the method to BP100 and
omiganan forebodes a good predictive power, in spite of all the
simplifications and approximations in the model. Hopefully, along
with an increasing awareness of the relevance of partition and
threshold events to the activity of AMPs, more datasets will
become available against which our method can be applied and
validated.
Finally, more than a theoretical exercise in bridging biology
with physical-chemistry, the presented methodology provides a
basis for fast, cost-effective alternatives for screening libraries of
peptide drug leads before actual biological testing. The predictive
relationships can also be coupled with drug design algorithms,
further improving the process. This work demonstrates that it is
possible to use a purely physical-chemical reasoning to understand,
model, and predict the mechanisms of complex biological
interactions such as AMP-mediated bacterial death, with applica-
tions that, in this case, may ultimately lead to a faster, more
efficient antibiotic drug development.
Limitations to the application of the model
It must be remarked that although our model performed well
with omiganan and BP100 it is too simple to precisely predict the
activity of all AMPs against all types of bacteria. The use of the
partition constant implies the assumption of equilibrium in
membrane binding; this might never be attained in practical
timescales for cases where bacteria present effective barriers to free
diffusion towards the membrane (e. g., a very thick or cation-
containing peptidoglycan layer [42]). The model can, nonetheless,
account for differences in the activity of a peptide against distinct
strains so long these result from differences in membrane
composition, as those generally entail a change in Kp or P : L
.
Another limitation to the applicability of the model stems from
the working hypothesis that peptide action depends on a critical
membrane-bound concentration threshold: peptides like the
apidaecins [43] that exert their action independently of some sort
of cooperativity in the membrane are not contemplated. Still,
membrane disruption by either lysis or poration is not a
requirement of the model; the activity of peptides that target
intracellular components can still be modelled as long as
translocation into the cytoplasm is a threshold-dependent step.
Multiple disruptive thresholds are often observed with model
membranes, which may complicate analysis if identification of the
relevant threshold is not possible. Such is the case in Figure 2 and
in one of the data sources used for predicting the MHC of melittin
Figure 1. Application of the MIC prediction method to AMP-
membrane threshold data. Published threshold data [7,10] on the
interaction of the AMPs BP100 (circles) and omiganan (triangles) with
POPC:POPG 1:2 unilamellar vesicles were fit with Equation 7, yielding
intercepts of 1:8+0:5mM and 6:8+0:3 mM , respectively. The lowest
MIC values measured against Gram-negative bacteria are indicated for
omiganan [38] (diagonal hatching) and BP100 [34] (horizontal hatching)
next to the ½P threshold axis; the intercepts, predictive of the MIC, lie
within few mM of these values.
doi:10.1371/journal.pone.0028549.g001
Figure 2. Application of theMIC predictionmethod to thresholds
in BP100 interaction with multilamellar vesicles. a) Optical density
of a suspension of multilamellar vesicles (60mM POPC:POPG 1:2) at
different concentrations of added BP100. Arrows indicate critical
threshold points. b) Plot and linear fit, according to Equation 7, of critical
points in panel a) and in similar curves obtained with different lipid
concentrations; empty and full symbols denote the first and second
critical points, respectively, of each curve. The intercept of the line fitted to
the second critical points (which correspond to the P : L determined
elsewhere [10]) estimates a MIC of 2:1+0:9 mM . The value is both close to
the estimate in Figure 1 and to the observed MIC range of BP100 [34],
indicated next to the ½BP100 threshold axis (hatched box).
doi:10.1371/journal.pone.0028549.g002
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[22]. Lacking further information on the relationship between
these disruptive points and the in vivo activity of the peptides, we
opted to combine predictions from the different thresholds into a
single range (as long as the predicted MIC/MHC was a positive
value). This, of course, resulted in a broadened prediction interval
and it is a possible reason why the MHC prediction spans almost
three orders of magnitude.
Finally, predictions may be sensitive to the precise constitution
of the membrane model. As stated earlier, this may justify different
bacterial susceptibilities to a given AMP, but it also stresses the
importance of using accurate models. An analysis of the
dependence of MIC predictions on membrane anionic density
has been included in the Supporting Information regarding the
relatively high anionic content of the bacterial membrane model
used in this work. Likewise, the lack of precision in the MHC
prediction may also result from the data having been collected in
three different zwitterionic erythrocyte membrane models [22,40],
two of which in the gel phase [22]. Indeed, when modelling the
essentially zwitterionic erythrocyte membrane, where the domi-
nance of electrostatic interactions is absent, one can expect peptide
partition to be quite sensitive to the particular constituents used.
Supporting Information
Text S1 Extended discussions on the 1) Analysis of pub-
lished data under the proposed model, 2) Influence of the
anionic charge of the membrane models on the conclusions
of this work, 3) Approximations in the partition model, and
4) Conversion from other constants, obtained under
different partition/binding formalisms.
(PDF)
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